Senior Director, Regulatory CMC
Required skills
- Regulatory CMC
- Biologics
- FDA
- EU
- IND
- IMPD
- BLA
- MAA
- Supplements
- Health Authority Interactions
Nice to have
- Mandarin Chinese
- Electronic Document Management Systems
- Document Review Tools
Role summary
The Senior Director, Regulatory Affairs, CMC, is responsible for global regulatory strategies and submissions for Summit products, covering development, commercialization, and lifecycle management. This role requires hands-on leadership in biologics regulatory CMC programs, working closely with cross-functional teams including Manufacturing, Analytical, Supply Chain, and Quality. Key responsibilities include developing CMC regulatory strategies, leading submission content authoring, managing health authority interactions, assessing regulatory risks, and ensuring compliance with global regulations. The position also involves mentoring talent and driving continuous process improvement within the Regulatory CMC function.
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Senior Director, Regulatory Affairs, CMC, is responsible for developing Regulatory Strategies and Submissions for Summit products globally. This role will provide regulatory strategy leadership, for development, commercialization and life cycle management of Summit products.
The Senior Director will work in close collaboration with cross functional teams including Manufacturing, Analytical, Supply Chain and Quality to develop regulatory strategies aligned with company goals. The Senior Director will bring hands on experience leading regulatory CMC programs in biologics and demonstrated leadership skills. This role is both strategic and hands-on and will be responsible for all the regulatory CMC activities.
Role and Responsibilities:
Experience, Education and Specialized Knowledge and Skills:
This is the pay for this position
Pay Transparency$220,000—$275,000 USDActual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Similar roles
- Executive Oncology Account Manager (Grand Rapids)Summit Therapeutics, Inc. · Grand Rapids, MI · Onsite
- Senior Clinical Trial ManagerSummit Therapeutics, Inc. · Remote · Remote
Global Regulatory CMC LeadModerna · Norwood, MA · Hybrid
Associate Principal Scientist, Regulatory CMC, Synthetic Moities of ADCs & BioconjugatesMSD · North Wales, PA · Hybrid
Associate Director, US Regulatory CMCBayer · Hanover · Hybrid- Director, Regulatory CMCBeam Therapeutics · Cambridge, MA · Onsite
